HG-14-10-04 10 mg | Purity Not Available
TargetMol
HG-14-10-04
Search Results
HG-14-10-04 5 mg | Purity Not Available
TargetMol
HG-14-10-04
BMS-986020 10 mg | 98.61%
TargetMol
BMS-986020
BMS-986020 5 mg | 98.61%
TargetMol
BMS-986020
Relebactam 1 mg | Purity Not Available
TargetMol
Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageRelebactam
Relebactam 25 mg | Purity Not Available
TargetMol
Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageRelebactam
Relebactam 5 mg | Purity Not Available
TargetMol
Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases.
More Information Supplier PageRelebactam
QS11 10 mg | 98.39%
TargetMol
QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier PageQS11
QS11 50 mg | 98.39%
TargetMol
QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier PageQS11
QS11 5 mg | 98.39%
TargetMol
QS11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregulate β-catenin nuclear translocation. Also reduces in vitro migration of metastatic human breast cancer cells.
More Information Supplier PageQS11